Primary Site >> Colorectal Cancer

Gene >> GCG

Journal: Regul Pept. 1987 Jan;17(1):9-29.
Title: Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells.
Author: Fiocca, R|Rindi, G|Capella, C|Grimelius, L|Polak, J M|Schwartz, T W|Yanaihara, N|Solcia, E
PMID: 2882565
Journal: J Investig Med. 2001 Jan;49(1):119-26.
Title: Central role of the adipocyte in the metabolic syndrome.
Author: Bergman, R N|Van Citters, G W|Mittelman, S D|Dea, M K|Hamilton-Wessler, M|Kim, S P|Ellmerer, M
PMID: 11217141
Journal: Regul Pept. 2004 Sep 15;121(1-3):137-43.
Title: Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Author: Bulut, K|Meier, J J|Ansorge, N|Felderbauer, P|Schmitz, F|Hoffmann, P|Schmidt, W E|Gallwitz, B
PMID: 15256284
Journal: Regul Pept. 2006 Dec 10;137(3):147-55.
Title: DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells.
Author: Masur, K|Schwartz, F|Entschladen, F|Niggemann, B|Zaenker, K S
PMID: 16908079
Journal: Eur J Pharmacol. 2008 Jan 14;578(2-3):279-85.
Title: Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Author: Bulut, Kerem|Pennartz, Christian|Felderbauer, Peter|Meier, Juris J|Banasch, Matthias|Bulut, Daniel|Schmitz, Frank|Schmidt, Wolfgang E|Hoffmann, Peter
PMID: 17920582
Journal: Med Hypotheses. 2008 Aug;71(2):241-4.
Title: Why diabetes patients are more prone to the development of colon cancer?
Author: Jin, Tianru
PMID: 18456417
Journal: Cancer Res. 2008 Oct 1;68(19):7897-904.
Title: Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
Author: Koehler, Jacqueline A|Harper, Will|Barnard, Maja|Yusta, Bernardo|Drucker, Daniel J
PMID: 18829546
Journal: Hum Mutat. 2009 Apr;30(4):661-8.
Title: Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Author: Polakova, V|Pardini, B|Naccarati, A|Landi, S|Slyskova, J|Novotny, J|Vodickova, L|Bermejo, J L|Hanova, M|Smerhovsky, Z|Tulupova, E|Kumar, R|Hemminki, K|Vodicka, P
PMID: 19224585
Journal: BMC Cancer. 2009 Jun 18;9:193.
Title: The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
Author: Castillejo, Adela|Mata-Balaguer, Trinidad|Montenegro, Paola|Ochoa, Enrique|Lazaro, Rafael|Martinez-Canto, Ana|Castillejo, Maria-Isabel|Guarinos, Carla|Barbera, Victor-Manuel|Guillen-Ponce, Carmen|Carrato, Alfredo|Soto, Jose-Luis
PMID: 19538729
Journal: Carcinogenesis. 2010 Apr;31(4):666-70.
Title: Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic.
Author: Naccarati, A|Pardini, B|Polakova, V|Smerhovsky, Z|Vodickova, L|Soucek, P|Vrana, D|Holcatova, I|Ryska, M|Vodicka, P
PMID: 20110284
Journal: Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G1-8.
Title: The "cryptic" mechanism of action of glucagon-like peptide-2.
Author: Rowland, Katherine J|Brubaker, Patricia L
PMID: 21527727
Journal: Endocrinology. 2011 Sep;152(9):3362-72.
Title: Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Author: Koehler, Jacqueline A|Kain, Taylor|Drucker, Daniel J
PMID: 21771884
Journal: Turk J Gastroenterol. 2011 Aug;22(4):388-94.
Title: Does glucagon like peptide-2 receptor expression have any effect on the development of human colorectal cancer?
Author: Bengi, Goksel|Kayahan, Hasan|Akarsu, Mesut|Aysal, Anil|Sagol, Ozgul|Meral, Murat|Akpinar, Hale
PMID: 21948569
Journal: J Mol Diagn. 2012 May-Jun;14(3):264-73.
Title: The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.
Author: Medeiros, Fabiola|Lindor, Noralane M|Couch, Fergus J|Highsmith, W Edward Jr
PMID: 22426235
Journal: PLoS One. 2012;7(10):e46215.
Title: Genome-wide screening of genes regulated by DNA methylation in colon cancer development.
Author: Spisak, Sandor|Kalmar, Alexandra|Galamb, Orsolya|Wichmann, Barna|Sipos, Ferenc|Peterfia, Balint|Csabai, Istvan|Kovalszky, Ilona|Semsey, Szabolcs|Tulassay, Zsolt|Molnar, Bela
PMID: 23049694
Journal: Pharmacol Ther. 2013 Jul;139(1):87-94.
Title: Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy?
Author: Kannen, Vinicius|Garcia, Sergio Britto|Stopper, Helga|Waaga-Gasser, Ana Maria
PMID: 23583681
Journal: Med Hypotheses. 2014 Mar;82(3):255-6.
Title: Should GLP-1 receptor agonists be used with caution in high risk population for colorectal cancer?
Author: Sun, Yang|Fan, Lei|Meng, Jin|Zhang, Feng|Zhang, Dian|Mei, Qibing
PMID: 24424394
Journal: PLoS One. 2015 Nov 4;10(11):e0141921.
Title: Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Author: Fujita, Shunsuke|Ushio, Soichiro|Ozawa, Nana|Masuguchi, Ken|Kawashiri, Takehiro|Oishi, Ryozo|Egashira, Nobuaki
PMID: 26536615
Journal: Oncol Rep. 2016 Feb;35(2):676-82.
Title: The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
Author: Yorifuji, Naoki|Inoue, Takuya|Iguchi, Munetaka|Fujiwara, Kaori|Kakimoto, Kazuki|Nouda, Sadaharu|Okada, Toshihiko|Kawakami, Ken|Abe, Yosuke|Takeuchi, Toshihisa|Higuchi, Kazuhide
PMID: 26573958
Journal: Endocr Res. 2017 Aug;42(3):209-218.
Title: Exendin-4 does not modify growth or apoptosis of human colon cancer cells.
Author: Wenjing, He|Shuang, Yu|Weisong, Li|Haipeng, Xiao
PMID: 28318339
Journal: Peptides. 2017 May;91:49-57.
Title: Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway.
Author: Shawe-Taylor, Marianne|Kumar, J Dinesh|Holden, Whitney|Dodd, Steven|Varga, Akos|Giger, Olivier|Varro, Andrea|Dockray, Graham J
PMID: 28363795
Journal: Pharmacogn Mag. 2017 Apr-Jun;13(50):275-280.
Title: Phytochemical and Biological Evaluations of Arum hygrophilum Boiss. (Araceae).
Author: Afifi, Fatma U|Kasabri, Violet|Litescu, Simona|Abaza, Ismail F|Tawaha, Khalid
PMID: 28539721
Journal: Oncotarget. 2017 Jul 31;8(47):82531-82540.
Title: Functional polymorphisms in the promoter region of miR-17-92 cluster are associated with a decreased risk of colorectal cancer.
Author: Sun, Ruifen|Liang, Yundan|Yuan, Fang|Nie, Xinwen|Sun, Hong|Wang, Yanyun|Yu, Tao|Gao, Linbo|Zhang, Lin
PMID: 29137282
Journal: Epidemiology. 2018 Mar;29(2):246-253.
Title: Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes.
Author: Abrahami, Devin|Yin, Hui|Yu, Oriana H Y|Pollak, Michael N|Azoulay, Laurent
PMID: 29283894
Journal: Asian Pac J Cancer Prev. 2018 Mar 27;19(3):693-698.
Title: Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population
Author: Shamsdin, Seyedeh Azra|Karimi, Mohammad Hossein|Hosseini, Seyed Vahid|Geramizadeh, Bita|Fattahi, Mohamad Reza|Mehrabani, Davood|Moravej, Ali
PMID: 29580042
Journal: Cancer Med. 2018 Jun;7(6):2555-2566.
Title: Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence.
Author: Wu, Zhuoxuan|Liu, Zhen|Ge, Weiting|Shou, Jiawei|You, Liangkun|Pan, Hongming|Han, Weidong
PMID: 29659199